Skip to content
healthcare.dev
Get a free key

BRIUMVI

NDC 73150-150, ublituximab, injection, solution, concentrate, from TG Therapeutics, Inc..

Product NDC
73150-150
Status
Listed
Labeler
TG Therapeutics, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761238
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73150-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • UBLITUXIMAB150 mg/6mL

Pharmacologic classes

CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
73150-150-06731500150061 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06) / 6 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3a77cd8c-811b-407c-9140-d0c5c26435c2

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=73150-150

Use it

Look up 73150-150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73150-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73150-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.